Dupilumab Shown to Reduce COPD Exacerbations Substantially in New Phase 3 Data
This data from the NOTUS trial is set to be submitted to the FDA alongside the phase 3 BOREAS trial data later in the year.
Stay updated with breaking news from Confirming Potential. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This data from the NOTUS trial is set to be submitted to the FDA alongside the phase 3 BOREAS trial data later in the year.
Bavarian Nordic A/S Bavarian Nordic Reports New Preclinical Data for COVID-19 Vaccine Confirming Potential for Broad Protection against SARS-CoV2 Variants Bavarian Nordic Reports New Preclinical Data for COVID-19 Vaccine Confirming Potential for Broad Protection against SARS-CoV2 Variants COPENHAGEN, Denmark, April 29, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today reported additional preclinical data for the capsid virus-like particle (cVLP) COVID-19 vaccine candidate, ABNCoV2, confirming its ability to induce neutralizing antibodies against SARS-CoV-2 variants. Bavarian Nordic p...